These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 1731500)

  • 1. Response of pancreatic carcinoma to 5-fluorouracil and leucovorin.
    Grinblatt DL; Benson AB
    Am J Med; 1992 Jan; 92(1):107-9. PubMed ID: 1731500
    [No Abstract]   [Full Text] [Related]  

  • 2. Identifying ideal candidates for nanoliposomal topoisomerase inhibitors in metastatic pancreatic adenocarcinoma.
    Yu K
    Clin Adv Hematol Oncol; 2018 Sep; 16 Suppl 17(9):9-10. PubMed ID: 30807562
    [No Abstract]   [Full Text] [Related]  

  • 3. Meta-analysis of Modified FOLFIRINOX Regimens for Patients With Metastatic Pancreatic Cancer.
    Usón Junior PLS; Rother ET; Maluf FC; Bugano DDG
    Clin Colorectal Cancer; 2018 Sep; 17(3):187-197. PubMed ID: 29615310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Translating landmark trial-based evidence to the front lines of care for pancreatic cancer: the evolving trial-based and guideline-supported role for nanoliposomal topoisomerase inhibitors in metastatic pancreatic adenocarcinoma.
    Lima CMSR
    Clin Adv Hematol Oncol; 2018 Sep; 16 Suppl 17(9):3-5. PubMed ID: 30807559
    [No Abstract]   [Full Text] [Related]  

  • 5. Metastatic pancreatic ductal adenocarcinoma: diagnosis and treatment with a view to the future.
    Pokorny AMJ; Chin VT; Nagrial AM; Yip D; Chantrill LA
    Intern Med J; 2018 Jun; 48(6):637-644. PubMed ID: 29898269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized trial of 5-fluorouracil, leucovorin and cisplatin in advanced pancreatic cancer.
    Huguier M; Barrier A; Valinas R; Flahault A; Adloff M; Pezet D; Jaeck D; Millat B;
    Hepatogastroenterology; 2001; 48(39):875-8. PubMed ID: 11462946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Changes in chemotherapy for pancreatic adenocarcinoma].
    Hammel P
    Gastroenterol Clin Biol; 2002; 26(6-7):603-4. PubMed ID: 12193859
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical benefit with cisplatin, hydroxyurea and 5-fluorouracil/leucovorin in advanced pancreatic adenocarcinoma.
    Raymond E; de Gramont A; Louvet C; Tournigand C; Demuynck B; Beerblock K; Carola E; Krulik M
    Eur J Cancer; 1997 Apr; 33(4):696-7. PubMed ID: 9274458
    [No Abstract]   [Full Text] [Related]  

  • 9. High-dose folinic acid, 5-fluorouracil bolus and infusion in advanced pancreatic adenocarcinoma: a pilot study.
    Louvet C; Beerblock K; de Gramont A; Varette C; Demuynck B; Bennamoun M; Cady J; Delfau S; Maisani JE; Krulik M
    Eur J Cancer; 1993; 29A(8):1217. PubMed ID: 8518038
    [No Abstract]   [Full Text] [Related]  

  • 10. Ifosfamide plus 5-fluorouracil for treatment of adenocarcinoma of the pancreas.
    Loehrer PJ; Williams SD; Nichols CR
    Cancer Treat Rep; 1987 Nov; 71(11):1115-6. PubMed ID: 3119208
    [No Abstract]   [Full Text] [Related]  

  • 11. Intra-arterial infusion of 5-fluorouracil, leucovorin, epirubicin and carboplatin (FLEC regimen) in unresectable pancreatic cancer: results of a ten-year experience.
    Mambrini A; Sanguinetti F; Pacetti P; Caudana R; Iacono C; Guglielmi A; Guadagni S; Del Freo A; Fiorentini G; Cantore M
    In Vivo; 2006; 20(6A):751-5. PubMed ID: 17203761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FOLFOX regimen in pancreatic acinar cell carcinoma: case report and review of the literature.
    Simon M; Bioulac-Sage P; Trillaud H; Blanc JF
    Acta Oncol; 2012 Mar; 51(3):403-5. PubMed ID: 21961498
    [No Abstract]   [Full Text] [Related]  

  • 13. Intra-arterial chemotherapy of advanced pancreatic cancer: a single center experience.
    Milandri C; Calzolari F; Passardi A; Tison C; Giampalma E; Cecconetto L; Golfieri R
    Hepatogastroenterology; 2007 Dec; 54(80):2373-7. PubMed ID: 18265668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5-Fluorouracil plus leucovorin as adjuvant treatment of an experimental liver tumor in rats.
    Carlsson G; Gustavsson BG; Spears CP; Hafström LO
    Anticancer Res; 1990; 10(3):813-6. PubMed ID: 2369095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resectable pancreatic adenocarcinomas: will neoadjuvant FOLFIRINOX replace upfront surgery in the standard of care?
    Antonios A; Gharios J; Tohme C
    Future Oncol; 2017 May; 13(11):951-953. PubMed ID: 28481149
    [No Abstract]   [Full Text] [Related]  

  • 16. FOLFOX+Nab-Paclitaxel (FOLFOX-A) for Advanced Pancreatic Cancer: A Brown University Oncology Research Group Phase I Study.
    Safran H; Charpentier KP; Perez K; Mantripragada K; Miner T; DiPetrillo T; Kuritzky B; Apor E; Bishop K; Luppe D; Mitchell K; Rosati K
    Am J Clin Oncol; 2016 Dec; 39(6):619-622. PubMed ID: 26523444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An increasingly common challenge: management of the complete responder with multi-focal metastatic colorectal cancer.
    Schrag D; Weiser M; Schattner M; Shia J; Akhurst T
    J Clin Oncol; 2005 Mar; 23(9):1799-802. PubMed ID: 15774773
    [No Abstract]   [Full Text] [Related]  

  • 18. Orthotopic and heterotopic murine models of pancreatic cancer and their different responses to FOLFIRINOX chemotherapy.
    Erstad DJ; Sojoodi M; Taylor MS; Ghoshal S; Razavi AA; Graham-O'Regan KA; Bardeesy N; Ferrone CR; Lanuti M; Caravan P; Tanabe KK; Fuchs BC
    Dis Model Mech; 2018 Jul; 11(7):. PubMed ID: 29903803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvant chemotherapy by FOLFOX for gastric hepatoid adenocarcinoma.
    Velut G; Mary F; Wind P; Aparicio T
    Dig Liver Dis; 2014 Dec; 46(12):1135-6. PubMed ID: 25179158
    [No Abstract]   [Full Text] [Related]  

  • 20. [Chemotherapy in adenocarcinomas of the pancreas].
    Huguier M
    Gastroenterol Clin Biol; 2002 Nov; 26(11):1063; discussion 1063-4. PubMed ID: 12483149
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.